Australia's oldest melanoma survivor steps up to save lives on his 105th birthday

Australia's oldest melanoma survivor steps up to save lives on his 105th birthday

11 March 2021

He beat melanoma at 101 thanks to breakthrough immunotherapy treatment, and four years later World War II veteran Bert Collins is taking steps to help save others from the deadly disease.

Bert today celebrated his 105th birthday at his Bankstown home, dedicating the milestone to urging his fellow Australians to join him in helping raise $500,000 for research into new life-saving melanoma treatments.

‘I figured something had to get me in the end, and so no doubt melanoma would be it,’ Bert said. ‘But research saved my life, and so I am delighted to be stepping up at 105 to help save others.’

Bert is taking part in this year’s Melanoma March campaign, where Aussies are urged to leave their footprint on melanoma by buying a $30 digital footprint, personalising it with a message of support, and sharing it to socials. Melanoma Institute Australia wants to cover Australia in digital footprints by the end of the month.

With no social accounts to share his personalised footprint, Bert is going ‘old school’ and will be leaving real footprints in his backyard in March. He’s not sure how many steps he’ll take, but the one-time ballroom dancer and avid gardener is confident he will get outside every day.

‘This is my way of giving back, and my 105th birthday wish is for other Australians to help me by buying their own digital footprint and personalising it with a message of support,’ Bert said.

Bert’s melanoma had already spread to his brain, lungs and liver when he was diagnosed with the disease in 2017. Deemed by his local oncologist to be too frail for any treatment, he was referred to Melanoma Institute Australia where he met oncologist Associate Professor Alex Menzies who is 65 years his junior.

‘Although Bert’s melanoma was advanced, he was otherwise well and was much fitter than most men 20 years younger,’ Associate Professor Menzies said. ‘So we immediately started a short course of treatment hoping for the best. I’d never had a patient as senior as Bert, so we didn’t know exactly how his body would respond,’ he said.

After just four doses of immunotherapy, which harnesses the body’s own immune system to rally and fight the cancer cells, Bert’s tumours had disappeared and he had no toxicity from treatment. He ceased treatment at that point and four years later remains disease free, making him Australia’s oldest melanoma survivor.

Associate Professor Menzies says ‘Bert has my number’ in case he ever needs it.

Bert knows he was one of the lucky ones. Some 50% of advanced melanoma patients don’t respond to the new treatments that saved his life, with an estimated 1300 Aussies expected to die from the disease this year. Australia has the highest melanoma rates in the world with one person diagnosed with the disease every 30 minutes.

‘Thanks to ongoing research, we have come so far in finding new and more effective treatments for melanoma but we still have a long way to go if we are to save more lives,’ Associate Professor Menzies said. ‘Bert is amazing, he is a true Aussie legend who is continuing to live a life of service to help others, and I hope all of Australia gets behind him.’

To buy join Bert in buying a digital footprint and watch Australia be progressively covered in footprints, go to www.melanomamarch.org.au


MEDIA - For more information, please contact:
Jennifer Durante |Melanoma Institute Australia | 0412 798 990 | jennifer.durante@melanoma.org.au

Community invests in MIA's new trial
19 Jul 2016

Community invests in MIA's new trial

The community has responded generously to our recent appeal to fund a specialised nursing position in an exciting new clinical trial. 

New trial giving options
18 Jul 2016

New trial giving options

We have developed a unique clinical trial that will use existing drugs to target rare genes in melanoma patients.

Melanoma research summary from ASCO
07 Jul 2016

Melanoma research summary from ASCO

Data presented at the recent ASCO Annual Meeting showcased advances in melanoma research, particularly long-term survival data.

Our Privacy Policy has been updated
06 Jul 2016

Updated privacy policy

We value your privacy and want you to be familiar with how we collect, use and disclose your information.

Can cognitive technology assist with melanoma identification?
29 Jun 2016

Can cognitive technology assist with melanoma identification?

Melanoma Institute Australia has partnered with IBM Research in Australia to help further advance melanoma identification using cognitive technology.

'4 Questions With...' Series
24 Jun 2016

'4 Questions With...' Series

CEO Carole Renouf chats to senior clinicians and researchers as part of our "4 Questions With..." short video series. 

Stop the Spread campaign shortlisted
22 Jun 2016

Stop the Spread campaign shortlisted

MIA's 'Stop the Spread' campaign has been shortlisted in the 2016 Cannes Lions International Festival of Creativity.

Merkel Cell Carcinoma: the hidden skin cancer
22 Jun 2016

Merkel Cell Carcinoma: the hidden skin cancer

Merkel cell carcinoma is a rare but aggressive skin cancer that is often hard to diagnose.

A meeting of the minds
02 Jun 2016

A meeting of the minds

MIA's doctors are converging on Chicago this week along with 40,000 delegates from around the globe at the biggest oncology conference in the world.

MIA's Dermatology services expanded
27 May 2016

MIA's Dermatology services expanded

We are pleased to announce a recent expansion to the dermatology services at Melanoma Institute Australia.

5 Minutes with Maria Gonzalez
20 May 2016

5 Minutes with Maria Gonzalez

This International Clinical Trials Day we reflect on the importance of clinical trials and the people who dedicate their lives to helping melanoma patients today and in the future.

Melanoma eBook to educate GPs
12 May 2016

Melanoma eBook to educate GPs

MIA has launched its first eBook Melanoma Essentials – A Concise Guide, a resource for GPs and other medical, nursing and allied professionals to help them effectively diagnose and manage cases.

5 Minutes with Dr Scot Ebbinghaus
05 May 2016

5 Minutes with Dr Scot Ebbinghaus

Dr Scot Ebbinghaus chats to us about an exciting clinical trial at MIA and where melanoma treatment is headed in the future.

Opdivo available on PBS for advanced melanoma patients
01 May 2016

Opdivo available on PBS for advanced melanoma patients

A new melanoma treatment has been listed on the PBS today, giving another option for advanced melanoma patients. 

5 Minutes with Dr Louise Jackett
27 Apr 2016

5 Minutes with Dr Louise Jackett

MIA's Pathology Fellow Dr Louise Jackett tells us why she's joined our fellowship program to learn from the best.

MIA patient's plight highlighted in ABC series
27 Apr 2016

MIA patient's plight highlighted in ABC series

MIA doctors and patient have featured in the final episode of ABC’s ground-breaking series Keeping Australia Alive.

Recruiting: Pregnancy and moles study
26 Apr 2016

Recruiting: Pregnancy and moles study

Specialist dermatologists at MIA are researching moles during pregnancy and we are looking for study recruits.

The role of radiotherapy in melanoma
22 Apr 2016

The role of radiotherapy in melanoma

New research is re-writing the textbooks on what we know about melanoma by highlighting the effectiveness of radiotherapy as a treatment, reversing a long-held belief that melanoma was resistant to radiotherapy.

Australian melanoma rates take the silver – and that's good news
31 Mar 2016

Australian melanoma rates take the silver – and that's good news

However, Australia's burden of melanoma will stay very high over the next 15 years unless we do more. MIA's Professor Graham Mann explains.

Australia unites taking small steps to make a big difference for melanoma research
23 Mar 2016

Australia unites taking small steps to make a big difference for melanoma research

Thank you to everyone involved in making Melanoma March 2016 a huge success